Prab: CSV import

2025-02-15T11:22:20Z

CSV import

← Older revision		Revision as of 11:22, 15 February 2025
Line 1:		Line 1:
	~~'''~~Proglumide''' is a [[drug]] that functions as a [[cholecystokinin antagonist]], which is used primarily in the treatment of [[gastrointestinal disorders]] and certain types of [[cancer]]. It was first synthesized in the 1970s and has been used in various medical applications since then.		{{DISPLAYTITLE:Proglumide}}

	== ~~History~~ ==		== Proglumide ==
			[[File:Proglumide_structure.svg\|thumb\|right\|Chemical structure of Proglumide]]
			'''Proglumide''' is a drug that was originally developed as a [[cholecystokinin]] (CCK) antagonist. It has been used in the treatment of [[peptic ulcers]] and other gastrointestinal disorders. Proglumide works by inhibiting the action of CCK, a hormone that stimulates the secretion of gastric acid and the contraction of the gallbladder.

	Proglumide ~~was first synthesized in the 1970s by~~ a ~~team of researchers~~ at the ~~[[University~~ of ~~Florence]]~~ in ~~Italy. The drug was initially developed as a treatment for [[~~peptic ~~ulcer disease]], but its use has since expanded to include~~ other ~~gastrointestinal disorders and certain types of cancer~~.		== Mechanism of Action ==
			Proglumide acts as a competitive antagonist at the CCK receptors, specifically the CCK-A and CCK-B subtypes. By blocking these receptors, proglumide reduces the secretion of gastric acid and decreases gastrointestinal motility. This action helps in alleviating symptoms associated with peptic ulcers and other related conditions.

	== ~~Pharmacology~~ ==		== Clinical Uses ==
			Proglumide has been used primarily in the management of [[peptic ulcer disease]]. It helps in reducing gastric acid secretion and provides symptomatic relief. Although its use has declined with the advent of more effective treatments such as [[proton pump inhibitors]] and [[H2 receptor antagonists]], proglumide is still of interest in research settings.

	~~Proglumide works by blocking the action of the hormone~~ [[~~cholecystokinin~~]] ~~(CCK), which is involved in~~ the ~~regulation~~ of [[~~gastrointestinal motility~~]] ~~and [[pancreatic enzyme]] secretion~~. ~~By inhibiting the action~~ of ~~CCK, proglumide can reduce~~ the ~~symptoms~~ of ~~conditions such as~~ [[~~gastroesophageal reflux disease~~]] ~~(GERD)~~ and [[~~irritable bowel syndrome~~]] ~~(IBS)~~.		== Research and Other Uses ==
			In addition to its gastrointestinal applications, proglumide has been studied for its potential effects on [[pain management]]. It has been shown to enhance the analgesic effects of [[opioids]], potentially allowing for lower doses of opioids to be used in pain control. This property makes proglumide a subject of interest in the field of [[pain management]] and [[opioid]] research.

	== ~~Medical uses~~ ==		== Side Effects ==
			The side effects of proglumide are generally mild and may include [[nausea]], [[diarrhea]], and [[dizziness]]. As with any medication, it is important to use proglumide under the guidance of a healthcare professional.

	~~Proglumide is used primarily in the treatment of gastrointestinal disorders, including peptic~~ ulcer disease~~, GERD, and IBS. It can also be used to treat certain types of cancer, such as~~ [[~~pancreatic cancer~~]]~~, by inhibiting the growth of cancer cells.~~		== Related Pages ==
			* [[Cholecystokinin]]
			* [[Peptic ulcer disease]]
			* [[Gastric acid]]
			* [[Opioid]]
			* [[Pain management]]

	~~== Side effects ==~~		[[Category:Pharmacology]]
			[[Category:Gastroenterology]]
	Like all drugs, proglumide can cause side effects. These can include [[nausea]], [[vomiting]], [[diarrhea]], and [[abdominal pain]]. In rare cases, proglumide can cause more serious side effects, such as [[liver damage]] or [[allergic reactions]].		[[Category:Analgesics]]

	~~== See also ==~~

	* [[Cholecystokinin antagonist]]
	* [[Gastrointestinal disorders]]
	* [[Pancreatic cancer]]

	~~== References ==~~

	~~{{reflist}}~~

	[[Category:~~Drugs~~]]
	[[Category:~~Gastrointestinal drugs~~]]
	[[Category:~~Cancer treatments~~]]
	~~{{medicine-stub}}~~

Prab: CSV import

2024-03-02T14:36:20Z

CSV import

New page

'''Proglumide''' is a [[drug]] that functions as a [[cholecystokinin antagonist]], which is used primarily in the treatment of [[gastrointestinal disorders]] and certain types of [[cancer]]. It was first synthesized in the 1970s and has been used in various medical applications since then.

== History ==

Proglumide was first synthesized in the 1970s by a team of researchers at the [[University of Florence]] in Italy. The drug was initially developed as a treatment for [[peptic ulcer disease]], but its use has since expanded to include other gastrointestinal disorders and certain types of cancer.

== Pharmacology ==

Proglumide works by blocking the action of the hormone [[cholecystokinin]] (CCK), which is involved in the regulation of [[gastrointestinal motility]] and [[pancreatic enzyme]] secretion. By inhibiting the action of CCK, proglumide can reduce the symptoms of conditions such as [[gastroesophageal reflux disease]] (GERD) and [[irritable bowel syndrome]] (IBS).

== Medical uses ==

Proglumide is used primarily in the treatment of gastrointestinal disorders, including peptic ulcer disease, GERD, and IBS. It can also be used to treat certain types of cancer, such as [[pancreatic cancer]], by inhibiting the growth of cancer cells.

== Side effects ==

Like all drugs, proglumide can cause side effects. These can include [[nausea]], [[vomiting]], [[diarrhea]], and [[abdominal pain]]. In rare cases, proglumide can cause more serious side effects, such as [[liver damage]] or [[allergic reactions]].

== See also ==

* [[Cholecystokinin antagonist]]
* [[Gastrointestinal disorders]]
* [[Pancreatic cancer]]

== References ==

{{reflist}}

[[Category:Drugs]]
[[Category:Gastrointestinal drugs]]
[[Category:Cancer treatments]]
{{medicine-stub}}

Proglumide - Revision history

Prab: CSV import

Prab: CSV import